206 related articles for article (PubMed ID: 30276745)
1. Targeted Proteomics.
Chen Y; Liu L
Methods Mol Biol; 2019; 1871():265-277. PubMed ID: 30276745
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous quantification of protein phosphorylation sites using liquid chromatography-tandem mass spectrometry-based targeted proteomics: a linear algebra approach for isobaric phosphopeptides.
Xu F; Yang T; Sheng Y; Zhong T; Yang M; Chen Y
J Proteome Res; 2014 Dec; 13(12):5452-60. PubMed ID: 25403019
[TBL] [Abstract][Full Text] [Related]
3. Application of an LC-MS/MS method for the simultaneous quantification of human intestinal transporter proteins absolute abundance using a QconCAT technique.
Harwood MD; Achour B; Russell MR; Carlson GL; Warhurst G; Rostami-Hodjegan A
J Pharm Biomed Anal; 2015 Jun; 110():27-33. PubMed ID: 25796981
[TBL] [Abstract][Full Text] [Related]
4. A Combination of DNA-peptide Probes and Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS): A Quasi-Targeted Proteomics Approach for Multiplexed MicroRNA Quantification.
Xu F; Zhou W; Cao J; Xu Q; Jiang D; Chen Y
Theranostics; 2017; 7(11):2849-2862. PubMed ID: 28824720
[TBL] [Abstract][Full Text] [Related]
5. Comparison of liquid chromatography-tandem mass spectrometry-based targeted proteomics and conventional analytical methods for the determination of P-glycoprotein in human breast cancer cells.
Yang T; Xu F; Xu J; Fang D; Yu Y; Chen Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Oct; 936():18-24. PubMed ID: 23968647
[TBL] [Abstract][Full Text] [Related]
6. LC-MS/MS-based targeted proteomics quantitatively detects the interaction between p53 and MDM2 in breast cancer.
Zhang W; Zhong T; Chen Y
J Proteomics; 2017 Jan; 152():172-180. PubMed ID: 27826076
[TBL] [Abstract][Full Text] [Related]
7. A liquid chromatography-tandem mass spectrometry-based targeted proteomics assay for monitoring P-glycoprotein levels in human breast tissue.
Yang T; Chen F; Xu F; Wang F; Xu Q; Chen Y
Clin Chim Acta; 2014 Sep; 436():283-9. PubMed ID: 24972002
[TBL] [Abstract][Full Text] [Related]
8. Absolute Quantification of Middle- to High-Abundant Plasma Proteins via Targeted Proteomics.
Dittrich J; Ceglarek U
Methods Mol Biol; 2017; 1619():417-430. PubMed ID: 28674901
[TBL] [Abstract][Full Text] [Related]
9. Liquid chromatography/tandem mass spectrometry based targeted proteomics quantification of P-glycoprotein in various biological samples.
Zhang Y; Li N; Brown PW; Ozer JS; Lai Y
Rapid Commun Mass Spectrom; 2011 Jun; 25(12):1715-24. PubMed ID: 21598331
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous quantification of Cyt c interactions with HSP27 and Bcl-xL using molecularly imprinted polymers (MIPs) coupled with liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based targeted proteomics.
Zhang W; Zhang T; Chen Y
J Proteomics; 2019 Feb; 192():188-195. PubMed ID: 30237093
[TBL] [Abstract][Full Text] [Related]
11. Parallel Reaction Monitoring: A Targeted Experiment Performed Using High Resolution and High Mass Accuracy Mass Spectrometry.
Rauniyar N
Int J Mol Sci; 2015 Dec; 16(12):28566-81. PubMed ID: 26633379
[TBL] [Abstract][Full Text] [Related]
12. Systematic quantification of peptides/proteins in urine using selected reaction monitoring.
Selevsek N; Matondo M; Sanchez Carbayo M; Aebersold R; Domon B
Proteomics; 2011 Mar; 11(6):1135-47. PubMed ID: 21360671
[TBL] [Abstract][Full Text] [Related]
13. LC-MS/MS-based quantification of efflux transporter proteins at the BBB.
Gomez-Zepeda D; Taghi M; Smirnova M; Sergent P; Liu WQ; Chhuon C; Vidal M; Picard M; Thioulouse E; Broutin I; Guerrera IC; Scherrmann JM; Parmentier Y; Decleves X; Menet MC
J Pharm Biomed Anal; 2019 Feb; 164():496-508. PubMed ID: 30453156
[TBL] [Abstract][Full Text] [Related]
14. Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics.
Gröer C; Busch D; Patrzyk M; Beyer K; Busemann A; Heidecke CD; Drozdzik M; Siegmund W; Oswald S
J Pharm Biomed Anal; 2014 Nov; 100():393-401. PubMed ID: 25218440
[TBL] [Abstract][Full Text] [Related]
15. Clinical Proteomics: Liquid Chromatography-Mass Spectrometry (LC-MS) Purification Systems.
Henry M; Meleady P
Methods Mol Biol; 2017; 1485():375-388. PubMed ID: 27730564
[TBL] [Abstract][Full Text] [Related]
16. Screening method using selected reaction monitoring for targeted proteomics studies of nasal lavage fluid.
Mörtstedt H; Kåredal MH; Jönsson BA; Lindh CH
J Proteome Res; 2013 Jan; 12(1):234-47. PubMed ID: 23214469
[TBL] [Abstract][Full Text] [Related]
17. MSQ: a tool for quantification of proteomics data generated by a liquid chromatography/matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry based targeted quantitative proteomics platform.
Oh JH; Pan S; Zhang J; Gao J
Rapid Commun Mass Spectrom; 2010 Feb; 24(4):403-8. PubMed ID: 20069694
[TBL] [Abstract][Full Text] [Related]
18. Proteome research based on modern liquid chromatography--tandem mass spectrometry: separation, identification and quantification.
Fröhlich T; Arnold GJ
J Neural Transm (Vienna); 2006 Aug; 113(8):973-94. PubMed ID: 16835695
[TBL] [Abstract][Full Text] [Related]
19. A Quasi-direct LC-MS/MS-based Targeted Proteomics Approach for miRNA Quantification via a Covalently Immobilized DNA-peptide Probe.
Liu L; Xu Q; Hao S; Chen Y
Sci Rep; 2017 Jul; 7(1):5669. PubMed ID: 28720752
[TBL] [Abstract][Full Text] [Related]
20. MRM
Korte R; Brockmeyer J
Anal Bioanal Chem; 2016 Nov; 408(27):7845-7855. PubMed ID: 27590318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
